Low body mass index and lymphocytopenia associate with Mycobacterium avium complex pulmonary disease in patients with rheumatoid arthritis

References

• Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423:356–61.
   PubMed Web of Science ®Google Scholar
• Dixon WG, Symmons DPM, Lunt M, Watson KD, Hyrich KL, British Society for Rheumatology Biologics Register Control Centre Consortium, et al. On behalf of the British Society for Rheumatology Biologics Resister. Serious infection following anti-tumor necrosis factor α therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies. Arthritis Rheum. 2007;56:2896–904.
   PubMed Web of Science ®Google Scholar
• Doran MF, Crowson CS, Pond GR, O’Fallon WN, Gabriel SE. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum. 2002;46:2287–93.
   PubMed Web of Science ®Google Scholar
• Wolfe F, Caplan L, Michaud K. Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy. Arthritis Rheum. 2006;54:628–34.
   PubMed Web of Science ®Google Scholar
• Sakai R, Komano Y, Tanaka M, Nanki T, Koike R, Nagawasa H, et al. Time-dependent increased risk for serious infection from continuous use of tumor necrosis factor antagonists over three years in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2012;64:1125–34.
   PubMed Web of Science ®Google Scholar
• Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367–416.
   PubMed Web of Science ®Google Scholar
• Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society. Management of opportunistic mycobacterial infections: joint Tuberculosis Committee guidelines 1999. Thorax. 2000;55:210–8.
   PubMed Web of Science ®Google Scholar
• Field SK, Fisher D, Cowie RL. Mycobacterium avium complex pulmonary disease in patients without HIV infection. Chest. 2004;125:566–81.
   PubMedGoogle Scholar
• Field SK, Cowie RL. Lung disease due to the more common nontuberculous mycobacteria. Chest. 2006;129:1653–72.
   PubMed Web of Science ®Google Scholar
• Morimoto K, Iwai K, Uchimura K, Okumura M, Yoshiyama T, Yoshimori K, et al. A steady increase in nontuberculous mycobacteriosis mortality and estimated prevalence in Japan. Ann ATS. 2014;11:1–8.
   Google Scholar
• Brode SK, Jamieson FB, Ng R, Campitelli MA, Kwong JC, Paterson JM, et al. Risk of mycobacterial infections associated with rheumatoid arthritis in Ontario, Canada. Chest. 2014;146:563–72.
   PubMed Web of Science ®Google Scholar
• Liao TL, Lin CH, Shen GH, Chang CL, Lin CF, Chen DY. Risk for mycobacterial disease among patients with rheumatoid arthritis, Taiwan, 2001–2011. Emerg Infect Dis. 2015;21:1387–95.
   PubMed Web of Science ®Google Scholar
• Andrejak C, Thomsen VØ, Johansen IS, Riis A, Benfield TL, Duhaut P, et al. Nontuberculous pulmonary mycobacteriosis in Denmark: incidence and prognostic factors. Am J Respir Crit Care Med. 2010;181:514–21.
   PubMed Web of Science ®Google Scholar
• Winthrop KL, Baxter R, Liu L, Varley CD, Curtis JR, Baddley JW, et al. Mycobacterial disease and antitumor necrosis factor therapy in USA. Ann Rheum Dis. 2013;72:37–42.
   PubMed Web of Science ®Google Scholar
• Namkoong H, Kurashima A, Morimoto K, Hoshino Y, Hasegawa N, Ato M, et al. Epidemiology of pulmonary nontuberculous mycobacterial disease, Japan. Emerg Infect Dis. 2016;22:1116–7.
   PubMed Web of Science ®Google Scholar
• Kitada S, Kobayashi K, Ichiyama S, Takakura S, Sakatani M, Suzuki K, et al. Serodiagnosis of Mycobacterium avium-complex pulmonary disease using an enzyme immunoassay kit. Am J Respir Crit Care Med. 2008;177:793–7.
   PubMed Web of Science ®Google Scholar
• Remy-Jardin M, Remy J, Cortet B, Mauri F. Lung changes in rheumatoid arthritis: CT findings. Radiology. 1994;193:375–82.
   PubMed Web of Science ®Google Scholar
• Mori S, Cho I, Koga Y, Suhimoto M. Comparison of pulmonary abnormalities on high-resolution computed tomography in patients with early versus longstanding rheumatoid arthritis. J Rheumatol. 2008;35:1513–21.
   PubMed Web of Science ®Google Scholar
• Hirose W, Uchiyama T, Nemoto A, Harigai M, Itoh K, Ishizuka T, et al. Diagnostic performance of measuring antibodies to the glycopeptidolipid core antigen specific to Mycobacterium avium complex in patients with rheumatoid arthritis: results from a cross-sectional observational study. Arthritis Res Ther. 2015;17:R273.
   PubMed Web of Science ®Google Scholar
• Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62:2269–81.
   Google Scholar
• Moore EH. Atypical mycobacterial infection in the lung. CT appearance. Radiology. 1993;187:777–82.
   PubMed Web of Science ®Google Scholar
• Kitada S, Nishiuchi T, Hiraga N, Naka N, Hashimoto H, Yoshimura K, et al. Serological test and chest computed tomography findings in patients with Mycobacterium avium complex lung disease. Eur Respir J. 2007;29:1217–23.
   PubMed Web of Science ®Google Scholar
• Obayashi Y, Fujita J, Suemitsu I, Kamei T, Nii M, Takahara J. Successive follow-up of chest computed tomography in patients with Mycobacterium avium–intracellulare complex. Respir Med. 1999;93:11–5.
   PubMed Web of Science ®Google Scholar
• Akaike H. Information theory and an extension of the maximum likelihood principle. In: Petrov BN, Caski F, editors. Proceedings and the 2nd International Symposium on Information Theory. Budapest: Akadimiai Kiado; 1973. p. 267–81.
   Google Scholar
• Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3:32–5.
   PubMed Web of Science ®Google Scholar
• Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer LK, et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2012;64:625–39.
   PubMed Web of Science ®Google Scholar
• Harigai M, Mochida S, Mimura T, Koike T, Miyasaka N. A proposal for management of rheumatic disease patients with hepatitis B virus infection receiving immunosuppressive therapy. Mod Rheumatol. 2014;24:1–7.
   PubMed Web of Science ®Google Scholar
• Adjemian J, Oliver KN, Seitz AE, Holland SM, Prevots DR. Prevalence of nontuberculous mycobacteria lung disease in U.S. Medicare beneficiaries. Am J Respir Crit Care Med. 2012;185:881–6.
   PubMed Web of Science ®Google Scholar
• Liao TL, Lin CF, Chen YM, Liu HJ, Chen DY. Risk factors and outcomes of nontuberculous mycobacterial disease among rheumatoid arthritis patients: a case-control study in a TB endemic area. Sci Rep. 2016;6:29443.
   PubMed Web of Science ®Google Scholar
• Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. J Am Med Assoc. 1949;140:659–62.
   PubMed Web of Science ®Google Scholar